down arrow

Kwality Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE552U01010
  • NSEID:
  • BSEID: 539997
INR
817.95
40.95 (5.27%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2.69 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Kwality Pharmaceuticals Ltd stock-summary
stock-summary
Kwality Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Kwality Pharmaceuticals Limited was Incorporated on May 4th 1983 when its founder Mr. Ramesh Arora was inspired to begin his own venture leaving behind the already flourishing family business of spinning and aromatics. With little background of finished pharmaceuticals and high held spirits and will, he started this business. He received his first drug license in 1981 approved for liquid oral manufacturing. Presently, the Company has 48 different sections available at their production centres.
Company Coordinates stock-summary
Company Details
Village Nagkalan, Majitha Road Amritsar Punjab : 143601
stock-summary
Tel: 91-183-2774321-25
stock-summary
cs@kwalitypharma.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.38 Cr
Number of Shares
1.04 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Oct-2017
1.04
10.38
5188099
10
Bonus
18-Jul-2016
51.88
5.19
180000
10
Public Issues
18-Jul-2016
51.88
5.19
180000
10
Public Issues
31-Mar-2014
50.08
5.01
275930
10
Allotment of Equity To Others
23-Feb-2014
47.32
4.73
1200000
10
Allotment of Equity To Others
10-May-2012
35.32
3.53
-160000
10
Forfeited Shares
26-Mar-2012
36.92
3.69
49781
10
Allotment of Equity To Others
31-Jan-2012
36.42
3.64
160000
10
Allotment of Equity To Others
18-Jan-2010
34.82
3.48
208000
10
Allotment of Equity To Others
07-Nov-2009
32.74
3.27
430000
10
Allotment of Equity To Others
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ramesh Arora (26.01%)

Highest Public shareholder

Deepak Bansal (10.63%)

Individual Investors Holdings

33.25%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Ramesh Arora
Managing Director
39.0 lacs
Ajay Arora
Whole-time Director
39.0 lacs
Ravi Shanker Singh
Independent Director
20.0 k
Geeta Arora
Whole-time Director
15.0 lacs
Anju Arora
Whole-time Director
15.0 lacs
Aditya Arora
Whole Time Director & CFO
27.0 lacs
Pankaj Takkar
Independent Director
1.3 lacs
Kiran Kumar Verma
Independent Director
1.21 lacs
Gurpreet Kaur
Company Sec. & Compli. Officer
0
Kartik Kapur
Independent Director
2.0 k
Sachin Seth
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Stock-in-Trade
0.6702
0%
 
100
Purchase of Stock-in-Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
84 Cr
(Quarterly Results - Dec 2024)
Net Profit:
9 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 849 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.39

stock-summary
Return on Equity

14.07%

stock-summary
Price to Book

3.34